Summary:
- The article discusses the latest advancements and challenges in the development of CRISPR-based gene-editing therapies.
- It highlights the clinical progress of treatments for genetic disorders, such as sickle-cell disease, while addressing concerns regarding off-target effects and long-term safety monitoring.